Table I.
Characteristic | White (n=74,891, 83%) | Black (n=15,527, 17%) | P |
---|---|---|---|
Age | 68 +/− 11.4 | 64 +/− 11.5 | < .001 |
Male Sex | 48,038 (64) | 8,518 (55) | < .001 |
Procedure Type: | < .001 | ||
Bypass | 26,579 (35) | 4,684 (30) | |
PVI | 44,152 (59) | 8,310 (54) | |
Amputation | 4,160 (6) | 2,533 (16) | |
Indication | < .001 | ||
Asymptomatic | 4,046 (6) | 483 (3) | |
claudication | 27,706 (38) | 3,634 (25) | |
rest pain | 11,116 (15) | 2,575 (25) | |
tissue loss | 22,481 (31) | 6,203 (43) | |
acute ischemia | 7,000 (10) | 1,356 (9) | |
CLTI | 40,597 (56) | 10,134 (70) | |
Smoking | 61,506 (82) | 11,628 (75) | < .001 |
Prior PVI | 35,111 (47) | 6,145 (40) | < .001 |
Medicaid/Self-Pay | 4,898 (8) | 2,128 (16) | < .001 |
Hypertension | 65,227 (87) | 14,319 (93) | < .001 |
Diabetes | 37,396 (50) | 10,292 (66) | < .001 |
CAD | 34,541 (46) | 5,673 (37) | < .001 |
CHF | 12,933 (17) | 3,310 (21) | < .001 |
COPD | 20,230 (27) | 3,072 (20) | < .001 |
BMI | < .001 | ||
Underweight | 2,932 (4) | 774 (5) | |
Normal | 22,317 (30) | 4,836 (31) | |
Overweight | 25,268 (34) | 4,809 (31) | |
Obese | 24,374 (33) | 5,108 (33) | |
GFR<60 | 27,902 (37) | 6,485 (42) | < .001 |
Dialysis | 3,918 (5) | 2,609 (17) | < .001 |
Case Urgency: | < .001 | ||
Elective | 60,327 (81) | 11,739 (76) | |
Urgent | 12,176 (16) | 3,062 (20) | |
Emergent | 2,154 (3) | 596 (4) | |
Medications | |||
Aspirin | 53,978 (72) | 10,481 (68) | < .001 |
Statin | 51,965 (70) | 10,234 (66) | < .001 |
P2Y12 inhibitor | 26,184 (35) | 5,433 (35) | 0.69 |
Dual Antiplatelet | 20,732 (28) | 4,105 (27) | 0.004 |
Any antiplatelet | 59,430 (80) | 11,809 (77) | < .001 |
Volume Quintiles | < .001 | ||
1 (<70/yr) | 14,980 (20) | 3,209 (21) | |
2(71–112/yr) | 13,922 (19) | 3,018 (19) | |
3 (115–166/yr) | 16,418 (22) | 3,171 (20) | |
4 (170–254/yr) | 13,373 (18) | 3,522 (23) | |
5 (>257/yr) | 16,139 (22) | 2,586 (17) |